1,2,4-Trimethoxybenzene

1,2,4-Trimethoxybenzene

SCHEMBL2496227

COc1ccc(OC)c(OC)c1.O=S(=O)(Cl)Cl

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.75
CA1 P00915 1/20 0.75
CA2 P00918 1/20 0.75
CA7 P43166 1/20 0.75
CA9 Q16790 1/20 0.75
CA14 Q9ULX7 1/20 0.75
POLB P06746 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 5/20 0.50
CYP1A1 P04798 5/20 0.50
CYP1B1 Q16678 5/20 0.50
CYP1A2 P05177 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
GAA P10253 1/20 0.50
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532255 0.88 CA1 (0.63) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL29350371 0.87 CA12 (1.00) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL27777905 0.87 CA12 (1.00) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL481491 0.87 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL27549293 0.86 HDAC4 (0.54) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL27496448 0.82 CA12 (0.67) CA12CA1CA2CA7CA9
SCHEMBL6935981 0.82 CA12 (0.65) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL27740813 0.80 CA12 (0.86) CA12CA1CA2CA7CA9
1,2,4-Trimethoxybenzene SCHEMBL27582647 0.80 CA2 (0.86) CA12CA1CA2CA7CA9
SCHEMBL407215 0.80 L3MBTL1 (0.64) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 CA12 4013/4885CA1 2198/4885CA2 3439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.